Events Search and Views Navigation
11:00 am
Dr. Mark DeWitt, a leading industry expert, shares his secrets on success with the development of a CRISPR/Cas9-based strategy
Correction of the Sickle Cell Disease Mutation with CRISPR/Cas9 Sickle Cell Disease (SCD), one of the world’s most common genetic disorders, causes anemia and progressive multiorgan damage that typically shortens lifespan by decades; currently there is no broadly applicable curative therapy. A universal curative therapy for SCD would address a critical unmet medical need in the United States and worldwide. During this webinar, Dr. Mark DeWitt will discuss the development of a CRISPR/Cas9-based strategy to correct the mutation in CD34+...
Find out more »12:00 pm
Virginia Tech Executive MBA Online Information Session
Virginia Tech’s Executive MBA program option merges experiential learning modules, leadership development, and the vast Virginia Tech alumni network to elevate your career to the next level. During this information session, we will discuss the program curriculum, tuition and financial aid, application information, and more. CLICK HERE TO REGISTER
Find out more »